Combination of Icotinib and Gemcitabine as First-line Treatment in Pancreatic Cancer
Clinical trial NCT02278458 · UNKNOWN
Trial details
- NCT number
- NCT02278458
- Sponsor
- Betta Pharmaceuticals Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-01
- Primary completion
- 2016-01-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.